Johnson & Johnson: acquires Momenta
(CercleFinance.com) - Johnson & Johnson announces a definitive agreement to acquire Momenta Pharmaceuticals, a company that discovers and develops novel therapies for immune-mediated diseases, in a cash deal of approximately 6.
5 billion dollars.
The pharmaceuticals group will launch an offer on all of Momenta's shares at a price of 52.5 dollars each. The deal, subject to the majority of shares being tendered and other customary conditions, is expected to be closed in H2 2020.
Copyright (c) 2020 CercleFinance.com. All rights reserved.